Prosthetic Breast Reconstruction After Mastectomy

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Jan 9, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a type of breast reconstruction called the EXP-IMPL technique, which is used after a mastectomy—a surgery to remove breast tissue due to cancer. The goal is to see if this traditional method is still a good option for women who have had a mastectomy, in terms of how well it works, how it looks, and how satisfied patients are with the results. The study is observational, meaning researchers will watch and gather information without changing how the procedure is performed.

To participate in this trial, women aged 18 to 70 who are undergoing a mastectomy and plan to have prosthetic breast reconstruction might be eligible. Participants will need to provide written consent to join the study. Throughout the trial, participants can expect to share their experiences and feelings about their reconstruction, helping researchers understand if this method is still a valuable choice for women today.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Sex F
• • Patients undergoing mastectomy (R-m, SS-m, NSS-m)
• • Age 18 - 70
• • Prosthetic breast reconstruction (DTI or EXP-IMPL)
• • Written informed consent
• Exclusion Criteria:
• • Autologous breast reconstruction